Premier Biotech understands the complex challenges health and human service agencies face on a day-to-day basis. Whether decisions are made at the state or local level, each state is unique with varied drug testing needs.
Historically, contracts utilizing collection site testing have been awarded through RFP, containing specs and solutions written decades ago. Now with advancements in the science and capabilities of rapid oral fluid testing, agencies can leverage new solutions while reducing the challenges adherent with collection site testing.
Email Premier Biotech to begin a pilot utilizing rapid oral fluid testing with OralTox.
Traditional collection site testing may be putting the health and safety of donors and their families at risk, while costing significantly more compared to rapid oral fluid testing. Rapid oral fluid testing allows HHS agencies to action immediately with onsite results in just minutes.
Rapid oral fluid testing saves a great deal of time and costs significantly less than utilizing traditional collection sites.
Often times, the result of a drug test can be the determining factor in removing children from the home or keeping the family intact. Rapid screening acts as the first line of defense, identifying presumptive positive or negative results on-site. Rapid oral fluid testing also provides time and cost savings throughout almost every aspect of the process.